Genekam developed potential therapeutic human anitbodies against Chlamydia
Genekam has developed a number of new breast cancer tumor markers from blood samples
Genekam is developing complex solutions based on antibody conjugates for therapeutic and diagnostic use. The antibodies can be recombinant as well as monoclonal type. Conjugates will be based on beyond the state of art technology. Some of conjugates may have potential to be used as vaccines also.